Plasma hydroxyproline in uremia: Relationships with histologic and biochemical indices of bone turnover
- 1 January 1983
- journal article
- research article
- Published by Elsevier in Metabolic Bone Disease and Related Research
- Vol. 4 (5) , 297-303
- https://doi.org/10.1016/s0221-8747(83)80003-4
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- DETERIORATION OF RENAL BONE DISEASE IN PATIENTS TREATED WITH SALMON CALCITONINClinical Endocrinology, 1982
- Responses to salmon calcitonin in chronic renal failure: relation to histological and biochemical indices of bone turnoverEuropean Journal of Clinical Investigation, 1981
- 24,25-dihydroxy-cholecalciferol, a vitamin D sterol with qualitatively unique effects in uremic manMetabolic Bone Disease and Related Research, 1979
- Is 24,25-dihydroxycholecalciferol a calcium-regulating hormone in man?BMJ, 1978
- Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.Archives of Disease in Childhood, 1977
- Changes in Histologic and Biochemical Indexes of Bone Turnover after Bilateral Nephrectomy in Patients on HemodialysisNew England Journal of Medicine, 1977
- Non-protein-bound hydroxyproline in plasma in renal bone diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1971
- Tetracycline-based histological analysis of bone remodelingCalcified Tissue International, 1969
- Quantitative microradiography: A new approach in the evaluation of metabolic bone diseaseThe American Journal of Medicine, 1966
- A specific method for the analysis of hydroxyproline in tissues and urineAnalytical Biochemistry, 1960